What should men know about prostate-specific antigen screening before giving informed consent?
Open Access
- 31 October 1998
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 105 (4), 266-274
- https://doi.org/10.1016/s0002-9343(98)00257-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Predictors of Interest in Prostate-Specific Antigen Screening and the Impact of Informed Consent: What Should We Tell Our Patients?American Journal Of Medicine, 1997
- The Use and Interpretation of CommercialAPCGene Testing for Familial Adenomatous PolyposisNew England Journal of Medicine, 1997
- CLINICAL GUIDELINE: PART III: Screening for Prostate CancerAnnals of Internal Medicine, 1997
- The importance of patient preference in the decision to screen for prostate cancerJournal of General Internal Medicine, 1996
- Excavations at Tell Brak, 1996Iraq, 1996
- Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the EvidenceNew England Journal of Medicine, 1995
- Informed consent for percutaneous lung biopsy: comparison of two consent protocols based on patient recall after the procedure.American Journal of Roentgenology, 1995
- Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screeningUrology, 1995
- Informed Consent for Tests for Prostate CancerPublished by American Medical Association (AMA) ,1995
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993